WTO TRIPS Agreement spurs innovation in the Indian biopharmaceutical industry
The upgrading of India’s IP laws as a result of its WTO commitments has confounded sceptics by encouraging its generics companies to move towards innovation.
Intellectual property drives pharmaceutical innovation in emerging markets
Intellectual property reforms ushered in by TRIPS have stimulated a nascent boom in pharmaceutical innovation in middle-income countries.